Exam 50- Antineoplastic Flashcards
tumor initiation and progression
- genetic mutation leads to abnormal proliferation
- more mutations occur within cells
- advantageous mutations are selected so tumor becomes increasing malignant
___ cells before cancer is identified
10 billion
adverse affects of antineoplastic drugs to blood
anemia (low RBC)
thrombocytopenia (low platelet)
leukopenia (low WBC)
adverse affects of antioplastic drugs to the GI
nausea vomiting diarrhea anorexia mucositis
other advers affects of antioplastic drugs
opportunistic infections
alopecia (hair cells)
teratogenesis
secondary cancers
rationale for combined therapy
- decreased resistance
- increase tolerability
- increase efficacy
combination therapy combines drugs with different:
MOA
cell cycle phase activity
dose-limiting toxicity
Hodgkin’s Lymphoma combination therapy
ABVD A=doxorubicin (G2) B=bleomycin (G2) V=vinblasine (M) D=dacbazine (G1 and S)
G1 phase
prep for DNA replicatin
S phase
DNA replication
G2 phase
prep for mitotis
M phase
=Mitosis
separate of daughter chromosomes and cell division
Check points of Cell Cycle
- DNA damage checkpoint- in G1
- detects damage before entering S as DNA’s being synthesized - Spindle checkpoints - in M
detect any failure of spindle fibers to form properly
Phase specific drugs general
- most active at a particular phase of the cell cycle
- time dependent!!
- more effective against tumors exhibiting log growth pattern
phase non-specific drugs
- exert toxic effects on cell during cycle, but not a specific part
- effective in both high and low growth fraction tumors
- concentration dependent!! ∴ give highest dose tolerable